ENTX — Entera Bio Ltd.

—
Nasdaq · Health Care · Biotechnology · CIK 1638097 · Israel
Last close
$3.00
Market Cap
$521.77M
52W High
$4.20
52W Low
$0.91
ADV30
451,546
Next earnings
2026-11-13

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 0 -7,265,000 -15,597,000 277,040,000 265,883,000 2,758,000
Jun 2026 0 0 -4,563,000 -7,312,000 19,480,000 11,309,000 12,214,000
Mar 2026 0 0 -3,539,000 -3,505,000 13,129,000 4,137,000 2,442,000
Dec 2025 0 0 -3,042,000 -3,016,000 15,993,000 7,108,000 2,892,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-10,889,000
Investing CF
$-73,000
Financing CF
$10,513,000
CapEx
$-107,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.34
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-136,183,000
Inventory
—
Receivables
$105,000
ST Investments
—
EBIT TTM
$-14,400,000
Pretax Income TTM
$-17,033,000
Interest Exp TTM
$2,749,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$0
EBITDA
$-14,369,000
Free Cash Flow
$-6,684,875
Enterprise Value
$532,781,344
Total Cash
$11,309,000
Total Debt
$425,000
Shares Out
173,922,428
Trailing EPS
$-0.36
Book Value
$0.28
ROE
-138.9%
ROA
-46.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 42,000 -11,529,000 -11,439,000 15,993,000 2,892,000 13,101,000 -7,370,000
Dec 2024 181,000 -9,585,000 -9,541,000 9,390,000 1,310,000 8,080,000 -6,818,000
Dec 2023 0 -8,891,000 -8,889,000 11,765,000 1,379,000 10,386,000 -7,310,000
Dec 2022 134,000 -13,017,000 -13,071,000 13,127,000 1,373,000 11,754,000 -12,499,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$17,033,000
OpCashFlow TTM
—
Assets (Latest)
$19,480,000
Forward EPS
$-0.55

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.00 · spot: $3.26 · call volume: 156 · put volume: 10

Peers — same industry

TickerNameMarket CapLastDaily %
ETRA Electra Therapeutics, Inc. $524.10M $8.35 —
VALN Valneva SE $527.69M $5.57 —
SANA Sana Biotechnology, Inc. $563.31M $1.88 —
FENC FENNEC PHARMACEUTICALS INC. $479.44M $13.58 —
RGNX REGENXBIO Inc. $478.73M $7.24 —

News headlines (Yahoo Finance, 1h cache)

Entera Announces Third Quarter 2026 Financial Results and Business Updates
2026-11-06 21:15 · Yahoo
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
2026-10-27 12:00 · Yahoo
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at AS
2026-10-13 11:00 · Yahoo
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
2026-10-08 12:00 · Yahoo
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
2026-10-06 12:00 · Yahoo
Entera to Participate in Upcoming Fall Investor Conferences
2026-08-27 12:00 · Yahoo
Entera Bio shares slip as Q2 loss comes in wider than expected
2026-08-10 11:02 · Yahoo
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-31 20:30 · Yahoo
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
2026-07-27 12:30 · Yahoo
ENTX Stock On Track For Best Day In Over 5 Years — What’s Driving The Rally?
2026-06-22 18:29 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.